Status:
WITHDRAWN
Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
The aim of the protocol is to study the resting brain activation profile of 3 groups of people, using a new fMRI procedure, called fMRI-SAM. fMRI-SAM will be applied to 25 Alzheimer's disease (AD) pat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Alzheimer's disease of mild to moderate severity (25 patients)
- Amnestic MCI patients (25 patients)
- 55-75 year-old patients
- Exclusion criteria:
- Any other cause of dementia for AD patients
- Any stroke
- Any disease with a negative vital prognosis
Exclusion
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00412048
Start Date
April 1 2012
End Date
February 1 2018
Last Update
November 14 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.